Visiongain, a independent media company, issued the following news release:. Visiongain's new report Pharmaceutical Packaging Market Report 2017-2027: Global Forecasts by Material, Product Delivery System and Geography indicates that the pharmaceutical packaging market will see over $89.5 bn in revenue in 2017.. The lead analyst of the report said:
Albany, NY 08/18/2018 Drug Delivery Systems Market: Snapshot. The global drug delivery systems market was valued approximately US$ 510 Bn in 2016 and is anticipated to expand at a CAGR of over 6.9% from 2017 to 2025 to reach approximately US$ 900 Bn by 2025. For instance, on September 2017, Baxter International Inc. announced the launch of De
Albany, NY 08/18/2018 Global Intravenous Immunoglobulin Market: Analyst's Estimations. In the recent past, IVIG have proven their worth in treating autoimmune diseases such as primary humoral immunodeficiency, multiple sclerosis, immune thrombocytopenia purpura, autoimmune haemolytic anemia, and Kawasaki syndrome. On the basis of indication,
Neurocrine Biosciences, Inc. today announced it will present data from its movement disorders programs, including additional long-term results for INGREZZA capsules, the first U.S. Food and Drug Administration approved treatment for adults with tardive dyskinesia, and data analyses from a Phase III study on opicapone, an investigational treatment f
CAMBRIDGE- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, today announced it has agreed on the structure and key terms of value-based agreements with leading health insurers for ONPATTRO lipid complex injection, a first-of-its-kind RNA interference therapeutic for the treatment of the polyneuropathy of hereditary...
CAMBRIDGE- Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the United States Food and Drug Administration approved ONPATTRO lipid complex injection, a first-of-its-kind RNA interference therapeutic, for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
CRANBURY- Amicus Therapeutics today announced that the U.S. Food and Drug Administration has granted accelerated approval of Galafold 123 mg capsules. As a condition of accelerated approval, Amicus Therapeutics will continue to study Galafold in a confirmatory Phase 4 program. John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeu
Antares Pharma announced that the U.S. Food and Drug Administration has approved Teva Pharmaceutical, epinephrine auto injector drug-device combination product indicated for emergency treatment of severe allergic reactions including those that are life threatening in adults and certain pediatric patients. We are extremely pleased with the FDA
Rockville, WA 08/17/2018 According to Fact.MR' s recently collated research report, a spectacular growth has been envisaged for the global dual chamber prefilled syringes market in the forecast period. Worldwide sales of dual chamber prefilled syringes are poised to bring in approximately US$ 3,300 Mn revenues by 2026- end. Dual Chamber Prefi
The U.S. Food and Drug Administration today approved Onpattro infusion for the treatment of peripheral nerve disease caused by hereditary transthyretin-mediated amyloidosis in adult patients. This is the first FDA- approved treatment for patients with polyneuropathy caused by hATTR, a rare, debilitating and often fatal genetic disease characterized
Albany, NY 08/16/2018 This report analyzes the current and future scenario of the global oral thin films market. Rise in demand for thin film drug delivery systems, considerable research and development in the segment, low development cost as compared to new drugs, and strategic alliances between novel technology owners and pharmaceutical gia
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting from Osaka, Japan, by NewsRx journalists, research stated, "Nanogels, nanometer-sized hydrogel particles, have great potential as drug delivery carriers. The news correspondents obtained a q
Smoking-related deaths have reached six million a year worldwide Lexaria's patented drug delivery platform aims to deliver commonly smoked drugs in a non-smoking form factor that sidesteps smoking's hazards Second round of testing continues to indicate that patented DehydraTECH? platform provides rapid delivery with high bioavailability As wo
New York, NY 08/17/2018 Top key vendors in Needle Free Drug Delivery Device Market include are 3 M, Bioject Medical Technologies, Eternity Healthcare, Crossject, National Medical Products, Valeritas, INJEX, Neo Laboratories, PharmaJet, Medical International Technology, Bespak, Zogenix, Advantajet, InsuJet, Antares Pharma, D'Antonio Consultant
According to news originating from Fujian, People's Republic of China, by NewsRx correspondents, research stated, "To explore materials stable in alkaline solution, a linear ligands 1,4- benzenedi, in which the pyrazolate group was considered as a soft Lewis base, was used to reacted with two relative soft Lewis acid Ni and Zn metal ions, to constr
By a News Reporter-Staff News Editor at Drug Week Investigators publish new report on Drugs and Therapies- Drug Delivery Systems. According to news reporting out of Rome, Italy, by NewsRx editors, research stated, "In this work, deacylated gellan gum and the plasticizer glycerol were used as primary components for the preparation of thin films in
According to news reporting originating in Miyagi, Japan, by NewsRx journalists, research stated, "Retinal degenerative diseases are a leading cause of irreversible blindness and visual impairment, affecting millions of people worldwide. The news reporters obtained a quote from the research from Tohoku University, "The design of drug delivery syste
The three leading firms in the market are Valeant Pharmaceuticals International, Inc., Alimera Sciences, and Santen Pharmaceutical Co., Ltd. These firms held more than 50% of the overall share of the market. Among them, Santen Pharmaceuticals and Valeant Pharmaceuticals dominates the market due to its wide range of ocular drugs it manufactures in t
Rockville, MD 08/17/2018 With increasing demand for efficient drug delivery systems, especially for injectable drug delivery, the need for innovative injectable drug delivery options has risen. For instance, Becton Dickinson has developed PosiFlush prefilled syringes with a 4% sodium citrate lock solution that can reduce the number of cathete
Recent Findings in Drug Delivery Systems Described by Researchers from University of Sheffield. According to news reporting originating from Sheffield, United Kingdom, by NewsRx correspondents, research stated, "Catalytic Janus colloids produce rapid motion in fluids by decomposing dissolved fuel. Our news editors obtained a quote from the research
By a News Reporter-Staff News Editor at Drug Week PHILADELPHIA- A new drug-delivery technology which uses red blood cells to shuttle nano-scale drug carriers, called RBC-hitchhiking, has been found in animal models to dramatically increase the concentration of drugs ferried precisely to selected organs, according to a study published in Nature...
Reports on Drug Delivery Systems Findings from University of Shanghai for Science& Technology Provide New Insights. According to news reporting originating from Shanghai, People's Republic of China, by NewsRx correspondents, research stated, "Structural nanocomposites that provide fast dissolving drug release profiles are highly in demand in...
Reports Outline Cystic Fibrosis Findings from Institute of Pharmacy. According to news originating from Innsbruck, Austria, by NewsRx correspondents, research stated, "The aim of this study was to develop a self-emulsifying drug delivery system containing the fluoroquinolone antibiotic ciprofloxacin exhibiting highly mucus permeating properties and
Reports Summarize Drug Delivery Systems Study Results from University of Ege. According to news reporting from Izmir, Turkey, by NewsRx journalists, research stated, "The aim of this study was to develop new Rosuvastatin calcium self nanoemulsifying drug delivery system and to evaluate the bioavailability and pharmacodynamic effect of RCa-SNEDDS in